State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD study, Beijing Key Laboratory of Active Substances Discovery and Drug Ability Evaluation, Department of Drug Metabolism, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Department of Health Management and Service, Cangzhou Medical College, Cangzhou 061001, China.
J Asian Nat Prod Res. 2024 Mar;26(3):353-371. doi: 10.1080/10286020.2023.2240722. Epub 2023 Aug 17.
The organic anion transporter 3 (OAT3), an important renal uptake transporter, is associated with drug-induced acute kidney injury (AKI). Screening and identifying potent OAT3 inhibitors with little toxicity in natural products, especially flavonoids, in reducing OAT3-mediated AKI is of great value. The five strongest OAT3 inhibitors from the 97 flavonoids markedly decreased aristolochic acid I-induced cytotoxicity and alleviated methotrexate-induced nephrotoxicity. The pharmacophore model clarified hydrogen bond acceptors and hydrophobic groups are the critical pharmacophores. These findings would provide valuable information in predicting the potential risks of flavonoid-containing food/herb-drug interactions and optimizing flavonoid structure to alleviate OAT3-related AKI.
有机阴离子转运蛋白 3(OAT3)是一种重要的肾脏摄取转运体,与药物引起的急性肾损伤(AKI)有关。在天然产物中筛选和鉴定具有较少毒性的有效 OAT3 抑制剂,特别是黄酮类化合物,对于减少 OAT3 介导的 AKI 具有重要价值。从 97 种黄酮类化合物中筛选出的 5 种最强的 OAT3 抑制剂可显著降低马兜铃酸 I 诱导的细胞毒性,并减轻甲氨蝶呤诱导的肾毒性。药效团模型阐明氢键受体和疏水区是关键药效团。这些发现将为预测含黄酮类食物/草药-药物相互作用的潜在风险和优化黄酮类结构以减轻 OAT3 相关 AKI 提供有价值的信息。